Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose L Perez

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Disease Markers|February 28, 2019
The Dynamic Use of <i>EGFR</i> Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer PatientsMónica Macías, Estibaliz Alegre, Gorka Alkorta-Aranburu, et al.
Oncoimmunology|January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.
Plos One|December 30, 2011
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytesCarlos Alfaro, Natalia Suarez, Carmen Oñate, et al.
International Journal of Cancer|September 21, 2010
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivoNatalia Suarez, Carlos Alfaro, Juan Dubrot, et al.
Cancer Immunology, Immunotherapy : CII|March 26, 2010
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organJuan Dubrot, Francisca Milheiro, Carlos Alfaro, et al.
Journal of the National Cancer Institute|August 14, 2013
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancerDaniel Ajona, María J Pajares, Leticia Corrales, et al.
Journal of Medical Microbiology|July 30, 2025
Dissecting rifampicin heteroresistance in <i>Mycobacterium tuberculosis</i>: integrating whole-genome sequencing with phenotypic and clonal validationKatherine Vallejos-Sanchez, Diego A Taquiri-Díaz, Omar A Romero-Rodriguez, et al.
European Journal of Immunology|May 8, 2021
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophilsAlvaro Teijeira, Saray Garasa, Maria Del Carmen Ochoa, et al.
Molecular Cancer Therapeutics|January 27, 2019
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal AntibodiesMaría E Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, et al.
Journal for Immunotherapy of Cancer|May 4, 2019
Immunotherapeutic effects of intratumoral nanoplexed poly I:CM Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Disease Markers|February 28, 2019
The Dynamic Use of <i>EGFR</i> Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer PatientsMónica Macías, Estibaliz Alegre, Gorka Alkorta-Aranburu, et al.
Oncoimmunology|January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.
Plos One|December 30, 2011
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytesCarlos Alfaro, Natalia Suarez, Carmen Oñate, et al.
International Journal of Cancer|September 21, 2010
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivoNatalia Suarez, Carlos Alfaro, Juan Dubrot, et al.
Cancer Immunology, Immunotherapy : CII|March 26, 2010
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organJuan Dubrot, Francisca Milheiro, Carlos Alfaro, et al.
Journal of the National Cancer Institute|August 14, 2013
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancerDaniel Ajona, María J Pajares, Leticia Corrales, et al.
Journal of Medical Microbiology|July 30, 2025
Dissecting rifampicin heteroresistance in <i>Mycobacterium tuberculosis</i>: integrating whole-genome sequencing with phenotypic and clonal validationKatherine Vallejos-Sanchez, Diego A Taquiri-Díaz, Omar A Romero-Rodriguez, et al.
European Journal of Immunology|May 8, 2021
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophilsAlvaro Teijeira, Saray Garasa, Maria Del Carmen Ochoa, et al.
Molecular Cancer Therapeutics|January 27, 2019
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal AntibodiesMaría E Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, et al.
Journal for Immunotherapy of Cancer|May 4, 2019
Immunotherapeutic effects of intratumoral nanoplexed poly I:CM Angela Aznar, Lourdes Planelles, Mercedes Perez-Olivares, et al.
Pageof 7